Pasithea Therapeutics Corp’s (KTTA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pasithea Therapeutics Corp is a Buy.
Pasithea Therapeutics Corp’s (KTTA) 20-Day exponential moving average is 0.49, while Pasithea Therapeutics Corp’s (KTTA) share price is $0.48, making it a Sell.
Pasithea Therapeutics Corp’s (KTTA) 50-Day exponential moving average is 0.48, while Pasithea Therapeutics Corp’s (KTTA) share price is $0.48, making it a Sell.
Pasithea Therapeutics Corp’s (KTTA) 10-Day exponential moving average is 0.49, while Pasithea Therapeutics Corp’s (KTTA) share price is $0.48, making it a Sell.
Pasithea Therapeutics Corp’s (KTTA) 100-Day exponential moving average is 0.52, while Pasithea Therapeutics Corp’s (KTTA) share price is $0.48, making it a Sell.
Pasithea Therapeutics Corp’s (KTTA) stock price is $0.48 and Pasithea Therapeutics Corp’s (KTTA) 50-day simple moving average is 0.47, creating a Buy signal.
Pasithea Therapeutics Corp’s (KTTA) stock price is $0.48 and Pasithea Therapeutics Corp’s (KTTA) 100-day simple moving average is 0.49, creating a Sell signal.
Pasithea Therapeutics Corp’s (KTTA) stock price is $0.48 and Pasithea Therapeutics Corp’s (KTTA) 200-day simple moving average is 0.60, creating a Sell signal.